News Summary
NeutralLinde delivered Q2 2026 results beating estimates with 11% EPS growth and raised full-year 2026 guidance to 8–9% EPS growth, demonstrating solid operational execution despite a 9% sales increase being driven largely by volume rather than underlying demand growth (4% organic). However, the stock fell on the earnings report and UBS cut its price target, with analyst commentary noting current valuation already reflects 2026 guidance, suggesting limited upside catalyst.
Red flags
- •Stock declined despite earnings beat, signaling market skepticism about valuation or forward outlook
- •Underlying sales growth of only 4% YoY indicates slower organic demand beneath headline 9% growth
- •UBS price target reduction ($622 to $612) in early August suggests analyst concern about near-term appreciation potential
- •Analyst downgrade citing valuation already reflects 2026 guidance, implying limited surprise upside ahead
- •1% foreign currency headwind to full-year guidance reflects macro exposure headwinds
Funds Buying (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Lone Pine Capital | Steve Mandel | 1.6M | +1.6M | $809M | 4.9% | — | NEW |
| D1 Capital | Dan Sundheim | 342K | +342K | $177M | 0.5% | — | NEW |
| Soros Fund Management | Soros Family Office | 267K | +7K | $139M | 1.8% | +3% | Existing |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.
Portfolio Context
Where LIN ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.
position #7 of this fund's book
- 4HOME DEPOT INC$918M
- 5APPLIED MATLS INC$873M
- 6MEDLINE INC$827M
- 7LINDE PLC$809M
- 8TERADYNE INC$722M
- 9CORNING INC$697M
- 10CARVANA CO$692M
position #11 of this fund's book
- 8PG&E CORP$180M
- 9RIVIAN AUTOMOTIVE INC$156M
- 10APPLE INC$153M
- 11LINDE PLC$139M
- 12LUMENTUM HLDGS INC$119M
- 13TKO GROUP HOLDINGS INC$116M
- 14SUPER MICRO COMPUTER INC$111M
position #31 of this fund's book
- 28MARTIN MARIETTA MATLS INC$199M
- 29COMPASS INC$188M
- 30COUPANG INC$179M
- 31LINDE PLC$177M
- 32TESLA INC$169M
- 33LATTICE SEMICONDUCTOR CORP$166M
- 34SEA LTD$161M
Values are quarter-end position sizes. Shown only for funds where LIN ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.
Signal History
| Quarter | Direction | Funds | Score | vs SPY |
|---|---|---|---|---|
| Q2 2026 | LONG | 3 | 4.36 | -10.8% |
| Q1 2026 | LONG | 4 | 5.50 | -22.0% |
Same issuer appearing in consecutive quarters — persistent institutional conviction. Returns are frozen at each archived quarter's last refresh.
Insider Activity
| Name | Title | Type | Shares | Price | Value | Filed | Src |
|---|---|---|---|---|---|---|---|
| Reynolds Paula Rosput | — | BUY | 100 | $479.12 | $0.05M | 2026-08-18 | ↗ |
Beneficial Ownership (13D/13G)
| Filer | Form | Shares | % of Class | Filed | Src |
|---|---|---|---|---|---|
| Vanguard Capital Management | SC 13G | 34.9M | 7.5% | 2026-04-30 | ↗ |
SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.
Congressional Trading
| Member | Chamber | State | Type | Amount Range | Transaction Date | Filed | Src |
|---|---|---|---|---|---|---|---|
| Alan Armstrong | senate | — | SELL | $15,001 - $50,000 | 2026-03-27 | 2026-07-21 | ↗ |
Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.